nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—CYP19A1—Paclitaxel—lung cancer	0.592	1	CbGbCtD
Testolactone—Ache—Vinorelbine—lung cancer	0.0116	0.0383	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—RHEB—lung cancer	0.00492	0.0545	CbGpPWpGaD
Testolactone—Alopecia—Pemetrexed—lung cancer	0.00461	0.0153	CcSEcCtD
Testolactone—Alopecia—Gefitinib—lung cancer	0.00458	0.0152	CcSEcCtD
Testolactone—Erythema—Pemetrexed—lung cancer	0.00454	0.0151	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—HSD17B10—lung cancer	0.00432	0.0479	CbGpPWpGaD
Testolactone—CYP19A1—FSH signaling pathway—AREG—lung cancer	0.00416	0.0461	CbGpPWpGaD
Testolactone—Malaise—Gefitinib—lung cancer	0.00407	0.0135	CcSEcCtD
Testolactone—Oedema—Crizotinib—lung cancer	0.00405	0.0134	CcSEcCtD
Testolactone—Alopecia—Teniposide—lung cancer	0.00373	0.0124	CcSEcCtD
Testolactone—Oedema—Pemetrexed—lung cancer	0.00371	0.0123	CcSEcCtD
Testolactone—Paraesthesia—Crizotinib—lung cancer	0.00364	0.0121	CcSEcCtD
Testolactone—Blood pressure increased—Paclitaxel—lung cancer	0.00359	0.0119	CcSEcCtD
Testolactone—Anorexia—Pemetrexed—lung cancer	0.00353	0.0117	CcSEcCtD
Testolactone—Decreased appetite—Crizotinib—lung cancer	0.00352	0.0117	CcSEcCtD
Testolactone—Anorexia—Gefitinib—lung cancer	0.00351	0.0116	CcSEcCtD
Testolactone—Decreased appetite—Pemetrexed—lung cancer	0.00322	0.0107	CcSEcCtD
Testolactone—Decreased appetite—Gefitinib—lung cancer	0.0032	0.0106	CcSEcCtD
Testolactone—Pain—Pemetrexed—lung cancer	0.00317	0.0105	CcSEcCtD
Testolactone—Pain—Gefitinib—lung cancer	0.00315	0.0104	CcSEcCtD
Testolactone—Blood pressure increased—Docetaxel—lung cancer	0.00304	0.0101	CcSEcCtD
Testolactone—Oedema—Teniposide—lung cancer	0.003	0.00995	CcSEcCtD
Testolactone—Anorexia—Teniposide—lung cancer	0.00286	0.00949	CcSEcCtD
Testolactone—Alopecia—Vinblastine—lung cancer	0.00285	0.00945	CcSEcCtD
Testolactone—Alopecia—Topotecan—lung cancer	0.00277	0.00918	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00276	0.0306	CbGpPWpGaD
Testolactone—Alopecia—Erlotinib—lung cancer	0.00274	0.00908	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.00273	0.0302	CbGpPWpGaD
Testolactone—Erythema—Erlotinib—lung cancer	0.0027	0.00894	CcSEcCtD
Testolactone—Decreased appetite—Teniposide—lung cancer	0.00261	0.00865	CcSEcCtD
Testolactone—Ill-defined disorder—Vinblastine—lung cancer	0.0026	0.00863	CcSEcCtD
Testolactone—Vomiting—Crizotinib—lung cancer	0.00258	0.00855	CcSEcCtD
Testolactone—Malaise—Vinblastine—lung cancer	0.00253	0.00839	CcSEcCtD
Testolactone—Ill-defined disorder—Topotecan—lung cancer	0.00253	0.00839	CcSEcCtD
Testolactone—Feeling abnormal—Teniposide—lung cancer	0.00247	0.0082	CcSEcCtD
Testolactone—Malaise—Topotecan—lung cancer	0.00246	0.00815	CcSEcCtD
Testolactone—Nausea—Crizotinib—lung cancer	0.00241	0.00799	CcSEcCtD
Testolactone—Glossitis—Methotrexate—lung cancer	0.00238	0.00789	CcSEcCtD
Testolactone—Alopecia—Vinorelbine—lung cancer	0.00237	0.00785	CcSEcCtD
Testolactone—Discomfort—Vinblastine—lung cancer	0.00236	0.00783	CcSEcCtD
Testolactone—Vomiting—Pemetrexed—lung cancer	0.00236	0.00781	CcSEcCtD
Testolactone—Vomiting—Gefitinib—lung cancer	0.00234	0.00776	CcSEcCtD
Testolactone—Erythema—Vinorelbine—lung cancer	0.00233	0.00773	CcSEcCtD
Testolactone—Discomfort—Topotecan—lung cancer	0.00229	0.0076	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00224	0.0248	CbGpPWpGaD
Testolactone—Oedema—Erlotinib—lung cancer	0.0022	0.0073	CcSEcCtD
Testolactone—Nausea—Pemetrexed—lung cancer	0.0022	0.0073	CcSEcCtD
Testolactone—Nausea—Gefitinib—lung cancer	0.00219	0.00725	CcSEcCtD
Testolactone—Anorexia—Vinblastine—lung cancer	0.00218	0.00724	CcSEcCtD
Testolactone—Ill-defined disorder—Vinorelbine—lung cancer	0.00216	0.00718	CcSEcCtD
Testolactone—Anorexia—Topotecan—lung cancer	0.00212	0.00703	CcSEcCtD
Testolactone—Malaise—Vinorelbine—lung cancer	0.0021	0.00697	CcSEcCtD
Testolactone—Anorexia—Erlotinib—lung cancer	0.0021	0.00696	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—lung cancer	0.00206	0.00683	CcSEcCtD
Testolactone—Paraesthesia—Vinblastine—lung cancer	0.00206	0.00682	CcSEcCtD
Testolactone—Paraesthesia—Topotecan—lung cancer	0.002	0.00663	CcSEcCtD
Testolactone—Decreased appetite—Vinblastine—lung cancer	0.00199	0.0066	CcSEcCtD
Testolactone—Testosterone Propionate—UGT1A1—lung cancer	0.00198	0.123	CrCbGaD
Testolactone—Discomfort—Vinorelbine—lung cancer	0.00196	0.00651	CcSEcCtD
Testolactone—Pain—Vinblastine—lung cancer	0.00196	0.0065	CcSEcCtD
Testolactone—Alopecia—Irinotecan—lung cancer	0.00195	0.00647	CcSEcCtD
Testolactone—Decreased appetite—Topotecan—lung cancer	0.00193	0.00641	CcSEcCtD
Testolactone—Decreased appetite—Erlotinib—lung cancer	0.00191	0.00635	CcSEcCtD
Testolactone—Vomiting—Teniposide—lung cancer	0.00191	0.00633	CcSEcCtD
Testolactone—Pain—Topotecan—lung cancer	0.0019	0.00631	CcSEcCtD
Testolactone—Alopecia—Gemcitabine—lung cancer	0.0019	0.00631	CcSEcCtD
Testolactone—Feeling abnormal—Vinblastine—lung cancer	0.00189	0.00626	CcSEcCtD
Testolactone—Pain—Erlotinib—lung cancer	0.00188	0.00624	CcSEcCtD
Testolactone—Erythema—Gemcitabine—lung cancer	0.00187	0.00621	CcSEcCtD
Testolactone—Feeling abnormal—Topotecan—lung cancer	0.00183	0.00608	CcSEcCtD
Testolactone—Anorexia—Vinorelbine—lung cancer	0.00181	0.00602	CcSEcCtD
Testolactone—Ill-defined disorder—Irinotecan—lung cancer	0.00178	0.00592	CcSEcCtD
Testolactone—Nausea—Teniposide—lung cancer	0.00178	0.00591	CcSEcCtD
Testolactone—Alopecia—Cisplatin—lung cancer	0.00177	0.00588	CcSEcCtD
Testolactone—Erythema—Cisplatin—lung cancer	0.00175	0.00579	CcSEcCtD
Testolactone—Ill-defined disorder—Gemcitabine—lung cancer	0.00174	0.00576	CcSEcCtD
Testolactone—Malaise—Irinotecan—lung cancer	0.00173	0.00575	CcSEcCtD
Testolactone—Paraesthesia—Vinorelbine—lung cancer	0.00171	0.00567	CcSEcCtD
Testolactone—Dexamethasone—ANXA1—lung cancer	0.00171	0.106	CrCbGaD
Testolactone—Malaise—Gemcitabine—lung cancer	0.00169	0.0056	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP2E1—lung cancer	0.00169	0.0187	CbGpPWpGaD
Testolactone—Decreased appetite—Vinorelbine—lung cancer	0.00165	0.00549	CcSEcCtD
Testolactone—Pain—Vinorelbine—lung cancer	0.00163	0.0054	CcSEcCtD
Testolactone—Alopecia—Etoposide—lung cancer	0.00162	0.00539	CcSEcCtD
Testolactone—Ill-defined disorder—Cisplatin—lung cancer	0.00162	0.00537	CcSEcCtD
Testolactone—Discomfort—Irinotecan—lung cancer	0.00162	0.00537	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.0016	0.0178	CbGpPWpGaD
Testolactone—Alopecia—Paclitaxel—lung cancer	0.00159	0.00528	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.00158	0.0175	CbGpPWpGaD
Testolactone—Discomfort—Gemcitabine—lung cancer	0.00158	0.00523	CcSEcCtD
Testolactone—Malaise—Cisplatin—lung cancer	0.00157	0.00522	CcSEcCtD
Testolactone—CYP19A1—Endogenous sterols—POMC—lung cancer	0.00157	0.0174	CbGpPWpGaD
Testolactone—Oedema—Irinotecan—lung cancer	0.00157	0.00521	CcSEcCtD
Testolactone—Erythema—Paclitaxel—lung cancer	0.00157	0.0052	CcSEcCtD
Testolactone—Feeling abnormal—Vinorelbine—lung cancer	0.00157	0.0052	CcSEcCtD
Testolactone—Oedema—Gemcitabine—lung cancer	0.00153	0.00507	CcSEcCtD
Testolactone—Anorexia—Irinotecan—lung cancer	0.0015	0.00496	CcSEcCtD
Testolactone—Ill-defined disorder—Etoposide—lung cancer	0.00148	0.00492	CcSEcCtD
Testolactone—Discomfort—Cisplatin—lung cancer	0.00147	0.00487	CcSEcCtD
Testolactone—Anorexia—Gemcitabine—lung cancer	0.00146	0.00483	CcSEcCtD
Testolactone—Vomiting—Vinblastine—lung cancer	0.00146	0.00483	CcSEcCtD
Testolactone—Ill-defined disorder—Paclitaxel—lung cancer	0.00146	0.00483	CcSEcCtD
Testolactone—Malaise—Etoposide—lung cancer	0.00144	0.00478	CcSEcCtD
Testolactone—Oedema—Cisplatin—lung cancer	0.00143	0.00473	CcSEcCtD
Testolactone—Vomiting—Topotecan—lung cancer	0.00141	0.00469	CcSEcCtD
Testolactone—Malaise—Paclitaxel—lung cancer	0.00141	0.00469	CcSEcCtD
Testolactone—Paraesthesia—Irinotecan—lung cancer	0.00141	0.00467	CcSEcCtD
Testolactone—Vomiting—Erlotinib—lung cancer	0.0014	0.00464	CcSEcCtD
Testolactone—Paraesthesia—Gemcitabine—lung cancer	0.00137	0.00455	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.00136	0.0151	CbGpPWpGaD
Testolactone—Decreased appetite—Irinotecan—lung cancer	0.00136	0.00453	CcSEcCtD
Testolactone—Nausea—Vinblastine—lung cancer	0.00136	0.00451	CcSEcCtD
Testolactone—Anorexia—Cisplatin—lung cancer	0.00136	0.00451	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CAT—lung cancer	0.00135	0.015	CbGpPWpGaD
Testolactone—Alopecia—Docetaxel—lung cancer	0.00135	0.00448	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.00135	0.0149	CbGpPWpGaD
Testolactone—Discomfort—Etoposide—lung cancer	0.00135	0.00446	CcSEcCtD
Testolactone—Pain—Irinotecan—lung cancer	0.00134	0.00445	CcSEcCtD
Testolactone—Erythema—Docetaxel—lung cancer	0.00133	0.00441	CcSEcCtD
Testolactone—Decreased appetite—Gemcitabine—lung cancer	0.00133	0.00441	CcSEcCtD
Testolactone—Nausea—Topotecan—lung cancer	0.00132	0.00438	CcSEcCtD
Testolactone—Discomfort—Paclitaxel—lung cancer	0.00132	0.00438	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTM2—lung cancer	0.00132	0.0146	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CNDP2—lung cancer	0.00132	0.0146	CbGpPWpGaD
Testolactone—Pain—Gemcitabine—lung cancer	0.00131	0.00434	CcSEcCtD
Testolactone—Nausea—Erlotinib—lung cancer	0.00131	0.00434	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.0013	0.0144	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM2—lung cancer	0.0013	0.0144	CbGpPWpGaD
Testolactone—Feeling abnormal—Irinotecan—lung cancer	0.00129	0.00429	CcSEcCtD
Testolactone—Oedema—Paclitaxel—lung cancer	0.00128	0.00425	CcSEcCtD
Testolactone—Paraesthesia—Cisplatin—lung cancer	0.00128	0.00424	CcSEcCtD
Testolactone—Feeling abnormal—Gemcitabine—lung cancer	0.00126	0.00418	CcSEcCtD
Testolactone—Anorexia—Etoposide—lung cancer	0.00124	0.00413	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RHEB—lung cancer	0.00124	0.0138	CbGpPWpGaD
Testolactone—Decreased appetite—Cisplatin—lung cancer	0.00124	0.00411	CcSEcCtD
Testolactone—Anorexia—Paclitaxel—lung cancer	0.00122	0.00405	CcSEcCtD
Testolactone—Pain—Cisplatin—lung cancer	0.00122	0.00404	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP1A1—lung cancer	0.00121	0.0134	CbGpPWpGaD
Testolactone—Vomiting—Vinorelbine—lung cancer	0.00121	0.00401	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2A7—lung cancer	0.00119	0.0132	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—lung cancer	0.00118	0.0131	CbGpPWpGaD
Testolactone—Feeling abnormal—Cisplatin—lung cancer	0.00117	0.00389	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2A7—lung cancer	0.00117	0.013	CbGpPWpGaD
Testolactone—Paraesthesia—Etoposide—lung cancer	0.00117	0.00389	CcSEcCtD
Testolactone—Paraesthesia—Paclitaxel—lung cancer	0.00115	0.00381	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—RAF1—lung cancer	0.00114	0.0126	CbGpPWpGaD
Testolactone—Decreased appetite—Etoposide—lung cancer	0.00113	0.00376	CcSEcCtD
Testolactone—Nausea—Vinorelbine—lung cancer	0.00113	0.00375	CcSEcCtD
Testolactone—Pain—Etoposide—lung cancer	0.00112	0.0037	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—MTOR—lung cancer	0.00111	0.0123	CbGpPWpGaD
Testolactone—Decreased appetite—Paclitaxel—lung cancer	0.00111	0.00369	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00111	0.0123	CbGpPWpGaD
Testolactone—Pain—Paclitaxel—lung cancer	0.00109	0.00363	CcSEcCtD
Testolactone—Oedema—Docetaxel—lung cancer	0.00108	0.0036	CcSEcCtD
Testolactone—Feeling abnormal—Etoposide—lung cancer	0.00108	0.00357	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA3—lung cancer	0.00106	0.0117	CbGpPWpGaD
Testolactone—Feeling abnormal—Paclitaxel—lung cancer	0.00105	0.0035	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MSH6—lung cancer	0.00105	0.0116	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA3—lung cancer	0.00105	0.0116	CbGpPWpGaD
Testolactone—Anorexia—Docetaxel—lung cancer	0.00103	0.00343	CcSEcCtD
Testolactone—Vomiting—Irinotecan—lung cancer	0.000998	0.00331	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.00098	0.0109	CbGpPWpGaD
Testolactone—Paraesthesia—Docetaxel—lung cancer	0.000974	0.00323	CcSEcCtD
Testolactone—Alopecia—Methotrexate—lung cancer	0.000973	0.00323	CcSEcCtD
Testolactone—Vomiting—Gemcitabine—lung cancer	0.000972	0.00322	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA4—lung cancer	0.00097	0.0107	CbGpPWpGaD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000967	0.0107	CbGpPWpGaD
Testolactone—Erythema—Methotrexate—lung cancer	0.000958	0.00318	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA4—lung cancer	0.000957	0.0106	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTA2—lung cancer	0.000945	0.0105	CbGpPWpGaD
Testolactone—Decreased appetite—Docetaxel—lung cancer	0.000943	0.00313	CcSEcCtD
Testolactone—Nausea—Irinotecan—lung cancer	0.000932	0.00309	CcSEcCtD
Testolactone—Pain—Docetaxel—lung cancer	0.000928	0.00308	CcSEcCtD
Testolactone—Prednisolone—CYP2A6—lung cancer	0.000919	0.0569	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AHR—lung cancer	0.000915	0.0101	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTA1—lung cancer	0.000912	0.0101	CbGpPWpGaD
Testolactone—Nausea—Gemcitabine—lung cancer	0.000908	0.00301	CcSEcCtD
Testolactone—Vomiting—Cisplatin—lung cancer	0.000906	0.00301	CcSEcCtD
Testolactone—Feeling abnormal—Docetaxel—lung cancer	0.000894	0.00297	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—SRC—lung cancer	0.000893	0.00989	CbGpPWpGaD
Testolactone—Ill-defined disorder—Methotrexate—lung cancer	0.000889	0.00295	CcSEcCtD
Testolactone—Malaise—Methotrexate—lung cancer	0.000864	0.00287	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1C1—lung cancer	0.000861	0.00954	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—UGT1A1—lung cancer	0.000848	0.00939	CbGpPWpGaD
Testolactone—Nausea—Cisplatin—lung cancer	0.000846	0.00281	CcSEcCtD
Testolactone—Alopecia—Doxorubicin—lung cancer	0.000842	0.00279	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—lung cancer	0.000839	0.00929	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—UGT1A1—lung cancer	0.000836	0.00926	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000834	0.00924	CbGpPWpGaD
Testolactone—Vomiting—Etoposide—lung cancer	0.00083	0.00275	CcSEcCtD
Testolactone—Erythema—Doxorubicin—lung cancer	0.00083	0.00275	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—MAPK3—lung cancer	0.000823	0.00912	CbGpPWpGaD
Testolactone—Vomiting—Paclitaxel—lung cancer	0.000814	0.0027	CcSEcCtD
Testolactone—Discomfort—Methotrexate—lung cancer	0.000806	0.00267	CcSEcCtD
Testolactone—Estrone—ABCG2—lung cancer	0.000796	0.0493	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—lung cancer	0.000795	0.00881	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000795	0.0088	CbGpPWpGaD
Testolactone—Nausea—Etoposide—lung cancer	0.000775	0.00257	CcSEcCtD
Testolactone—Ill-defined disorder—Doxorubicin—lung cancer	0.00077	0.00255	CcSEcCtD
Testolactone—Nausea—Paclitaxel—lung cancer	0.00076	0.00252	CcSEcCtD
Testolactone—Malaise—Doxorubicin—lung cancer	0.000748	0.00248	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—MDM2—lung cancer	0.000748	0.00829	CbGpPWpGaD
Testolactone—Anorexia—Methotrexate—lung cancer	0.000745	0.00247	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000731	0.0081	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—HPGDS—lung cancer	0.000721	0.00798	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—lung cancer	0.000713	0.0079	CbGpPWpGaD
Testolactone—Paraesthesia—Methotrexate—lung cancer	0.000702	0.00233	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTT1—lung cancer	0.000699	0.00774	CbGpPWpGaD
Testolactone—Discomfort—Doxorubicin—lung cancer	0.000698	0.00231	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2A6—lung cancer	0.000691	0.00766	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GCLC—lung cancer	0.000691	0.00766	CbGpPWpGaD
Testolactone—Vomiting—Docetaxel—lung cancer	0.00069	0.00229	CcSEcCtD
Testolactone—Decreased appetite—Methotrexate—lung cancer	0.00068	0.00225	CcSEcCtD
Testolactone—Oedema—Doxorubicin—lung cancer	0.000677	0.00225	CcSEcCtD
Testolactone—Pain—Methotrexate—lung cancer	0.000669	0.00222	CcSEcCtD
Testolactone—Drospirenone—PTGS2—lung cancer	0.00065	0.0403	CrCbGaD
Testolactone—Anorexia—Doxorubicin—lung cancer	0.000645	0.00214	CcSEcCtD
Testolactone—Nausea—Docetaxel—lung cancer	0.000644	0.00214	CcSEcCtD
Testolactone—Feeling abnormal—Methotrexate—lung cancer	0.000644	0.00214	CcSEcCtD
Testolactone—Estrone—CYP2E1—lung cancer	0.000632	0.0391	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000632	0.007	CbGpPWpGaD
Testolactone—Estrone—CYP1A1—lung cancer	0.000623	0.0386	CrCbGaD
Testolactone—Paraesthesia—Doxorubicin—lung cancer	0.000608	0.00202	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000593	0.00656	CbGpPWpGaD
Testolactone—Decreased appetite—Doxorubicin—lung cancer	0.000589	0.00195	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2E1—lung cancer	0.000588	0.00651	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—STK11—lung cancer	0.000581	0.00644	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2E1—lung cancer	0.00058	0.00642	CbGpPWpGaD
Testolactone—Pain—Doxorubicin—lung cancer	0.000579	0.00192	CcSEcCtD
Testolactone—Progesterone—CYP2A6—lung cancer	0.000572	0.0354	CrCbGaD
Testolactone—Feeling abnormal—Doxorubicin—lung cancer	0.000558	0.00185	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—AKT1—lung cancer	0.000555	0.00615	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2A6—lung cancer	0.000524	0.0324	CrCbGaD
Testolactone—Vomiting—Methotrexate—lung cancer	0.000497	0.00165	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000491	0.00544	CbGpPWpGaD
Testolactone—Methylprednisolone—ABCB1—lung cancer	0.000485	0.03	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—GSTP1—lung cancer	0.000485	0.00537	CbGpPWpGaD
Testolactone—Testosterone—ABCG2—lung cancer	0.000484	0.03	CrCbGaD
Testolactone—Triamcinolone—PTGS2—lung cancer	0.000481	0.0298	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTP1—lung cancer	0.000478	0.00529	CbGpPWpGaD
Testolactone—Dexamethasone—ABCG2—lung cancer	0.000468	0.029	CrCbGaD
Testolactone—Nausea—Methotrexate—lung cancer	0.000464	0.00154	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTM1—lung cancer	0.000445	0.00493	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM1—lung cancer	0.000439	0.00487	CbGpPWpGaD
Testolactone—Vomiting—Doxorubicin—lung cancer	0.000431	0.00143	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP1A1—lung cancer	0.000422	0.00468	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—lung cancer	0.00042	0.00465	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1A1—lung cancer	0.000416	0.00461	CbGpPWpGaD
Testolactone—Nausea—Doxorubicin—lung cancer	0.000402	0.00133	CcSEcCtD
Testolactone—Progesterone—CYP1A1—lung cancer	0.000401	0.0248	CrCbGaD
Testolactone—Betamethasone—PTGS2—lung cancer	0.000394	0.0244	CrCbGaD
Testolactone—Spironolactone—ABCB1—lung cancer	0.000394	0.0244	CrCbGaD
Testolactone—Prednisone—ALB—lung cancer	0.000389	0.0241	CrCbGaD
Testolactone—Testosterone—CYP1A1—lung cancer	0.000379	0.0235	CrCbGaD
Testolactone—Dexamethasone—CYP2E1—lung cancer	0.000372	0.023	CrCbGaD
Testolactone—CYP19A1—Metabolism—COL4A3BP—lung cancer	0.000371	0.00411	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AZIN2—lung cancer	0.000371	0.00411	CbGpPWpGaD
Testolactone—Prednisone—ABCB1—lung cancer	0.000371	0.023	CrCbGaD
Testolactone—Dexamethasone—CYP1A1—lung cancer	0.000367	0.0227	CrCbGaD
Testolactone—Methyltestosterone—ALB—lung cancer	0.000364	0.0225	CrCbGaD
Testolactone—Estrone—ALB—lung cancer	0.000347	0.0215	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000346	0.00384	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000345	0.00382	CbGpPWpGaD
Testolactone—Prednisolone—ABCB1—lung cancer	0.000342	0.0212	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000342	0.00379	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000339	0.00375	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000338	0.00374	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000335	0.00371	CbGpPWpGaD
Testolactone—Betamethasone—ABCB1—lung cancer	0.000335	0.0207	CrCbGaD
Testolactone—Estrone—ABCB1—lung cancer	0.000331	0.0205	CrCbGaD
Testolactone—CYP19A1—Metabolism—ATP5H—lung cancer	0.000316	0.0035	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—POMC—lung cancer	0.000315	0.00349	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00029	0.00321	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.000289	0.0032	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PLBD1—lung cancer	0.000281	0.00312	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000281	0.00311	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000277	0.00307	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000259	0.00286	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD17B10—lung cancer	0.000257	0.00285	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000252	0.00279	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000251	0.00278	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000243	0.00269	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CKB—lung cancer	0.000239	0.00265	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000232	0.00257	CbGpPWpGaD
Testolactone—Dexamethasone—PTGS2—lung cancer	0.000229	0.0142	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTM2—lung cancer	0.000225	0.00249	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CNDP2—lung cancer	0.000225	0.00249	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000219	0.00243	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTMR3—lung cancer	0.000219	0.00242	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PGAM1—lung cancer	0.000213	0.00236	CbGpPWpGaD
Testolactone—Progesterone—ABCB1—lung cancer	0.000213	0.0132	CrCbGaD
Testolactone—Testosterone—ALB—lung cancer	0.000211	0.0131	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP2A7—lung cancer	0.000203	0.00225	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000202	0.00224	CbGpPWpGaD
Testolactone—Testosterone—ABCB1—lung cancer	0.000201	0.0125	CrCbGaD
Testolactone—CYP19A1—Metabolism—SDC4—lung cancer	0.000199	0.00221	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000197	0.00219	CbGpPWpGaD
Testolactone—Dexamethasone—ABCB1—lung cancer	0.000195	0.0121	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000187	0.00207	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—RRM1—lung cancer	0.000181	0.00201	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA3—lung cancer	0.000181	0.00201	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—B4GALT5—lung cancer	0.00017	0.00189	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA4—lung cancer	0.000166	0.00184	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000166	0.00184	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000162	0.0018	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA2—lung cancer	0.000162	0.00179	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA1—lung cancer	0.000156	0.00173	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCC3—lung cancer	0.000154	0.00171	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKR1C1—lung cancer	0.000149	0.00165	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UGT1A1—lung cancer	0.000145	0.00161	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.00014	0.00155	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GNG11—lung cancer	0.00014	0.00155	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000139	0.00154	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALDOA—lung cancer	0.000133	0.00147	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA3—lung cancer	0.000129	0.00143	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000127	0.00141	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCG2—lung cancer	0.000126	0.00139	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ADCY1—lung cancer	0.000126	0.00139	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HPGDS—lung cancer	0.000123	0.00137	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ENO2—lung cancer	0.000123	0.00137	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPP2R1B—lung cancer	0.000122	0.00136	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000121	0.00134	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTT1—lung cancer	0.00012	0.00132	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GCLC—lung cancer	0.000118	0.00131	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2A6—lung cancer	0.000118	0.00131	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000118	0.0013	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ENO1—lung cancer	0.000112	0.00124	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000112	0.00124	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.00011	0.00122	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2E1—lung cancer	0.0001	0.00111	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NQO1—lung cancer	9.94e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.73e-05	0.00108	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.64e-05	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—STK11—lung cancer	8.96e-05	0.000992	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.41e-05	0.000931	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTP1—lung cancer	8.29e-05	0.000918	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CAT—lung cancer	8.06e-05	0.000893	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.02e-05	0.000888	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCB1—lung cancer	7.84e-05	0.000869	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TYMS—lung cancer	7.7e-05	0.000853	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTM1—lung cancer	7.62e-05	0.000844	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP1A1—lung cancer	7.22e-05	0.0008	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ERCC2—lung cancer	7.16e-05	0.000793	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—APOA1—lung cancer	6.19e-05	0.000686	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.93e-05	0.000657	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CG—lung cancer	5.65e-05	0.000626	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—POMC—lung cancer	5.38e-05	0.000596	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CREBBP—lung cancer	5.24e-05	0.000581	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CD—lung cancer	4.97e-05	0.000551	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALB—lung cancer	4.91e-05	0.000544	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CB—lung cancer	4.33e-05	0.00048	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS2—lung cancer	4.29e-05	0.000476	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTEN—lung cancer	3.74e-05	0.000415	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—EP300—lung cancer	3.57e-05	0.000396	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CA—lung cancer	2.64e-05	0.000293	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKT1—lung cancer	2.16e-05	0.000239	CbGpPWpGaD
